Cargando…
Ultra‐Specific Isolation of Circulating Tumor Cells Enables Rare‐Cell RNA Profiling
The clinical potential of circulating tumor cells (CTCs) in managing cancer metastasis is significant. However, low CTC isolation purities from patient blood have hindered sensitive molecular assays of these rare cells. Described herein is the ultra‐pure isolation of CTCs from patient blood samples...
Autores principales: | Jack, Rhonda M., Grafton, Meggie M. G., Rodrigues, Danika, Giraldez, Maria D., Griffith, Catherine, Cieslak, Robert, Zeinali, Mina, Kumar Sinha, Chandan, Azizi, Ebrahim, Wicha, Max, Tewari, Muneesh, Simeone, Diane M., Nagrath, Sunitha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039969/ https://www.ncbi.nlm.nih.gov/pubmed/27711257 http://dx.doi.org/10.1002/advs.201600063 |
Ejemplares similares
-
Sensitive capture of circulating tumour cells by functionalised graphene oxide nanosheets
por: Yoon, Hyeun Joong, et al.
Publicado: (2013) -
Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model
por: Zhang, Zhuo, et al.
Publicado: (2014) -
Trans-Renal Cell-Free Tumor DNA for Urine-Based Liquid Biopsy of Cancer
por: Dermody, Sarah M., et al.
Publicado: (2022) -
Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine
por: Praharaj, Prakash P., et al.
Publicado: (2018) -
High-Throughput Label-Free Isolation of Heterogeneous Circulating Tumor Cells and CTC Clusters from Non-Small-Cell Lung Cancer Patients
por: Zeinali, Mina, et al.
Publicado: (2020)